E-LIB Suche - Ergebnisse für: James, Ian E.

1

Two‐Part Phase 1 Multiple‐Ascending‐Dose Study to Evaluate ..:

Ramos, Kimberly A. ; James, Ian E. ; Skobieranda, Franck...
Clinical Pharmacology in Drug Development. 11 (2021) 1 - p. 51-62 , 2021

Link: https://doi.org/10.1002/..

2

A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Si..:

Fossler, Michael J. ; Schmith, Virginia ; Greene, Stephen A....
CNS Drugs. 34 (2020) 8 - p. 853-865 , 2020

Link: https://doi.org/10.1007/..

3

A First‐in‐Human Clinical Study With TRV734, an Orally Bioa..:

James, Ian E. ; Skobieranda, Franck ; Soergel, David G....
Clinical Pharmacology in Drug Development. 9 (2019) 2 - p. 256-266 , 2019

Link: https://doi.org/10.1002/..

4

A Novel EPO Receptor Agonist Improves Glucose Tolerance via..:

Scully, Michael S. ; Ort, Tatiana A. ; James, Ian E....
Experimental Diabetes Research. 2011 (2011) - p. 1-10 , 2011

Link: https://doi.org/10.1155/..

5

Mechanical injury potentiates proteoglycan catabolism induc..:

Sui, Yihong ; Lee, Jennifer H. ; DiMicco, Michael A....
Arthritis & Rheumatism. 60 (2009) 10 - p. 2985-2996 , 2009

Link: https://doi.org/10.1002/..

6

Structure Activity Relationships of 5-, 6-, and 7-Methyl-Su..:

Yamashita, Dennis S. ; Marquis, Robert W. ; Xie, Ren...
Journal of Medicinal Chemistry. 49 (2006) 5 - p. 1597-1612 , 2006

Link: https://doi.org/10.1021/..

7

Phenylbutyrates as potent, orally bioavailable vitronectin ..:

Miller, William H ; Manley, Peter J ; Cousins, Russell D...
Bioorganic & Medicinal Chemistry Letters. 13 (2003) 8 - p. 1483-1486 , 2003

Link: https://doi.org/10.1016/..

8

Proteoglycan degradation after injurious compression of bov..:

Patwari, Parth ; Cook, Michael N. ; DiMicco, Michael A....
Arthritis & Rheumatism. 48 (2003) 5 - p. 1292-1301 , 2003

Link: https://doi.org/10.1002/..

9

Potent and selective cathepsin L inhibitors do not inhibit ..:

James, Ian E. ; Marquis, Robert W. ; Blake, Simon M....
Journal of Biological Chemistry. 278 (2003) 34 - p. 32484 , 2003

Link: https://doi.org/10.1016/..

10

Potent and Selective Inhibition of Human Cathepsin K Leads ..:

Stroup, George B. ; Lark, Michael W. ; Veber, Daniel F....
Journal of Bone and Mineral Research. 16 (2001) 10 - p. 1739-1746 , 2001

Link: https://doi.org/10.1359/..

11

Human Osteoclast Cathepsin K Is Processed Intracellularly P..:

Dodds, Robert A. ; James, Ian E. ; Rieman, David...
Journal of Bone and Mineral Research. 16 (2001) 3 - p. 478-486 , 2001

Link: https://doi.org/10.1359/..

12

Antagonism of the Osteoclast Vitronectin Receptor with an O..:

Lark, Michael W. ; Stroup, George B. ; Dodds, Robert A....
Journal of Bone and Mineral Research. 16 (2001) 2 - p. 319-327 , 2001

Link: https://doi.org/10.1359/..

13

Potent and Selective Cathepsin L Inhibitors Do Not Inhibit ..:

James, Ian E. ; Marquis, Robert W. ; Blake, Simon M....
Journal of Biological Chemistry. 276 (2001) 15 - p. 11507-11511 , 2001

Link: https://doi.org/10.1074/..

14

CK?-8 [CCL23], a novel CC chemokine, is chemotactic for hum..:

Votta, Bartholomew J. ; White, John R. ; Dodds, Robert A....
Journal of Cellular Physiology. 183 (2000) 2 - p. 196-207 , 2000

Link: https://doi.org/10.1002/..

15

Injurious Mechanical Compression of Bovine Articular Cartil..:

Loening, Andreas M. ; James, Ian E. ; Levenston, Marc E....
Archives of Biochemistry and Biophysics. 381 (2000) 2 - p. 205-212 , 2000

Link: https://doi.org/10.1006/..